The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Newsletter 2005
 

Newsletter

2008

2007

2006

2005

2004

2003

2002

Content created 25 May 2005
Page updated 25 May 2005

Get Adobe Reader

Get Adobe Flash Player

In this Issue May 2005

 

Influenza Vaccine Information Paper and Brochure

New 'Flu Education Materials

National Asthma Council/Blackmores Alliance

ASCIA Annual Scientific Meeting, Queenstown NZ

Managing Pain Using Self-Management Approaches: Evidence and implementation

Education in Chronic Condition Self-Management 

Research Funding Opportunities 

Conference Diary 2005

New 'Flu Education Materials

The National Asthma Council has pooled its resources, together with those of the National Heart Foundation, Diabetes Australia, Asthma Foundations of Australia and the Australian Lung Foundation, to produce a comprehensive set of information materials about influenza and pneumococcal vaccinations.

The material clearly explains the role of influenza and pneumococcal vaccinations for people with asthma, COPD, heart disease and diabetes for health professionals and consumers.

Roles of influenza and pneumococcal vaccinations in subgroups with asthma, COPD, diabetes or heart disease is the 12 page health professional information paper.

VACCINE UPDATE for people with asthma, COPD, heart disease or diabetes. Should YOU have the influenza and pneumococcal vaccines? is the supporting 12 page consumer education brochure.

Both publications provide a definitive overview of the current Australian immunization guidelines for each of the four chronic conditions, including information on who should be immunized and who shouldn’t, backed up by the latest research, including current Cochrane reviews.
 

Roles of influenza and pneumococcal vaccinations in subgroups with asthma, COPD, diabetes or heart disease

 

"Vaccination of persons at risk of complications from influenza and pneumococcal disease is a key public health strategy for preventing associated morbidity and mortality.

Those most at risk include people aged 65 years and older, and people with medical conditions that increase the likelihood of complications from infections, for example, chronic respiratory diseases, diabetes and cardiovascular disease.

Influenza vaccination programs have been shown to reduce morbidity and mortality associated with infection in high-risk groups, prevent exacerbations and acute respiratory illness in those with chronic lung disease and reduce future ischaemic events in people with myocardial infarction. Pneumococcal vaccination has been shown to reduce the incidence of invasive pneumococcal disease in children and adults, including those with chronic conditions."

 
VACCINE UPDATE for people with asthma, COPD, heart disease or diabetes. Should YOU have the influenza and pneumococcal vaccines?

 

"If you have asthma, chronic obstructive pulmonary disease (COPD), heart disease or diabetes, you may have a higher risk of developing complications from viruses and infections.

COPD includes conditions like chronic bronchitis and emphysema.

Complications can include serious lung diseases such as pneumonia, ear infections, heart problems and blood infections.

This brochure helps you to find out whether you should be vaccinated with the influenza and/or pneumococcal vaccines. Many people are eligible for free influenza (flu) and pneumococcal vaccinations through government or health service programs.

This may vary from state to state, so check with your doctor or pharmacist to find out if you qualify."

 

To access these materials go to Information Papers and Brochures

Top of page

National Asthma Council and Blackmores Alliance

The National Asthma Council and Blackmores have joined in an alliance to provide information on asthma to consumers and health professionals interested in asthma and in complementary medicines. The National Asthma Council is writing some articles for Blackmores E-Newsletters to patients and health professionals.

One area of common interest is a published study looking at the treatment of asthma with the lipid extract of the New Zealand green-lipped mussel1. This small clinical trial showed that there may be some beneficial effect in patients with atopic asthma. Clinical trials have also indicated that Lyprinol (brand name) is effective in arthritis.

The National Asthma Council’s recent information paper and consumer brochure on Asthma and Complementary Therapies, funded by the Department of Health and Ageing, also provided information to consumers and health professionals interested in asthma and complementary therapies.

1. Emelyanov A, Fedoseev G, Krasnoschekova O, Abulimity A, Trendeleva T, Barnes PJ. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002; 20:596-600

Useful Resources

Asthma and Complementary Therapies A guide for health professionals

(www.nationalasthma.org.au/HTML/management/infopapers/health_professionals/5001_ct.asp)

Asthma and Complementary Therapies
(www.nationalasthma.org.au/HTML/management/infopapers/consumer/5001_ct.asp)

ASCIA Annual Scientific Meeting, Queenstown NZ

QueenstownThe theme for the Australasian Society of Clinical Immunology and Allergy Annual Scientific Meeting in Queenstown, New Zealand is excellence in clinical and laboratory immunology.

The Organising Committee has aimed to produce a quality program covering these areas and abstract submissions are invited with the deadline for receipt being 31st July.

The registration brochure for the ASCIA 2005 Annual Scientific Meeting  is now available and can be accessed via the ASCIA website.

ASCIA   
(http://www.allergy.org.au)

or directly to

ASCIA 2005
(http://tcc.co.nz/ascia2005)

Top of page

Managing Pain Using Self-Management Approaches:
Evidence and implementation - Reminder

CCSM logoThe half-day workshop, Managing Pain Using Self-Management Approaches: Evidence and implementation, will take place on August 19, in Sydney. Coordinated by the Australian Government Department of Health and Ageing, the program aims to provide the latest research and evidence for Chronic Condition Self-Management (CCSM) in Australia and internationally.

Keynote speakers include:

  • Professor Kate Lorig

  • Dr Malcolm Battersby

  • Mr John Belfrage

  • Dr Margarite Vale

  • Dr Anne-Marie Feyer

There will be a series of four case studies covering CCSM from the perspective of:

  • a Division of General Practice

  • a State Health Authority

  • a Non-government Organisation

  • an Indigenous Health Service

and a panel session: Implementing self-management programs and their impact on pain.

The workshop begins at 12 noon and the cost is $100.

For information / registration contact:
DC Conferences, Phone: 02 9954 4400.
Website: www.dcconferences.com.au/pinp2005.

Education in Chronic Condition Self-Management

Flinders University through the Flinders Human Behaviour & Health Research Unit is offering the Graduate Certificate in Health (Self-Management) through online study.

For all the details go to

Flinders Human Behaviour & Health Research Unit

(http://som.flinders.edu.au/FUSA/CCTU/On%20Line%20Training.htm) 

Research Funding Opportunities

The National Asthma Council would be pleased to list funding opportunities that may be available for asthma research. Submit brief details for consideration by email to editor@nationalasthma.com.au.

 

Conference Diary 2005

Submit brief conference/meeting details to the National Asthma Council for possible posting in our Conference Diary by email to editor@nationalasthma.com.au.

 

The Australian Asthma and Respiratory Educators Association Symposium
University House, Canberra.
4 and 5 August 2005
klangbridge@doh.health.nsw.gov.au 
Australian Asthma and Respiratory Educators Association
Managing Pain Using Self-Management Approaches: Evidence and implementation (Half-day Workshop)
Sydney Convention and Exhibition Centre
Sydney, Australia
19 August 2005
Information/registration
(http://www.dcconferences.com.au/pinp2005).

CCSM logo

16th Australasian Society of Clinical Immunology and Allergy (ASCIA) Annual Scientific Meeting
Queenstown, New Zealand
31 August - 4 September 2005
ASCIA Annual Scientific Meeting
(http://www.allergy.org.au)

ASCIA logo

10th Congress of APSR
1st Joint Congress of the APSR/ACCP
Guangzhou, China
November 11-14, 2005
APSR Information
(http://www.apsr2005.com)
APSR logo
IPCRG 3rd World Conference 
"Respiratory Disease in Primary Care – Quality of care"
8 - 11 June, 2006 
Radisson SAS Plaza Hotel, Oslo, Norway.

theipcrg.org/oslo2006  

(http://www.theipcrg.org/oslo2006/)

IPCRG 3rd World Conference 

Top of page